These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6728872)

  • 1. Effects of mecamylamine, nicotine, atropine and physostigmine on the phencyclidine-induced behavioral toxicity.
    Chaturvedi AK
    Pharmacol Biochem Behav; 1984 Apr; 20(4):559-66. PubMed ID: 6728872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cholinergic modifiers on phencyclidine-induced acute toxicity.
    Chaturvedi AK
    Pharmacol Res Commun; 1983 Mar; 15(3):291-305. PubMed ID: 6856659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
    Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
    Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral effects after intrathecal administration of cholinergic receptor agonists in the rat.
    Gillberg PG; Hartvig P; Gordh T; Sottile A; Jansson I; Archer T; Post C
    Psychopharmacology (Berl); 1990; 100(4):464-9. PubMed ID: 2320707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dorsal hippocampal muscarinic and nicotinic receptors are involved in mediating morphine reward.
    Rezayof A; Zatali H; Haeri-Rohani A; Zarrindast MR
    Behav Brain Res; 2006 Jan; 166(2):281-90. PubMed ID: 16191443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic drugs and 4-aminopyridine alter hypoxic-induced behavioral deficits.
    Gibson GE; Pelmas CJ; Peterson C
    Pharmacol Biochem Behav; 1983 Jun; 18(6):909-16. PubMed ID: 6136988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of phencyclidine, atropine and physostigmine, alone and in combination, on variable-interval performance in the squirrel monkey.
    Chait LD; Balster RL
    Pharmacol Biochem Behav; 1979 Jul; 11(1):37-42. PubMed ID: 115014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mecamylamine reverses physostigmine-induced attenuation of scopolamine-induced hyperactivity.
    O'Neill MF; Fernández AG; Gristwood RW; Palacios JM
    J Neural Transm Gen Sect; 1994; 96(1):9-18. PubMed ID: 7857593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol state-dependent memory: involvement of dorsal hippocampal muscarinic and nicotinic receptors.
    Rezayof A; Alijanpour S; Zarrindast MR; Rassouli Y
    Neurobiol Learn Mem; 2008 May; 89(4):441-7. PubMed ID: 18065245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia.
    Sienkiewicz-Jarosz H; Członkowska AI; Siemiatkowski M; Maciejak P; Szyndler J; Płaźnik A
    J Neural Transm (Vienna); 2000; 107(12):1403-12. PubMed ID: 11458993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular responses to injections of cholinomimetic drugs into the cerebral ventricles of unanaesthetized dogs.
    Lang WJ; Rush ML
    Br J Pharmacol; 1973 Feb; 47(2):196-205. PubMed ID: 4722036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of central cholinoceptors in Metrazol-induced convulsions.
    Rastogi SK; Puri JN; Sinha JN; Bhargava KP
    Psychopharmacology (Berl); 1979 Oct; 65(2):215-7. PubMed ID: 117491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine, physostigmine, atropine and mecamylamine: effects on force lever performance.
    Preston KL; Schuster CR; Seiden LS
    Pharmacol Biochem Behav; 1985 Nov; 23(5):781-8. PubMed ID: 4080764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
    Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
    Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the medial septum cholinoceptors in anxiogenic-like effects of nicotine.
    Zarrindast MR; Tajik R; Ebrahimi-Ghiri M; Nasehi M; Rezayof A
    Physiol Behav; 2013 Jul; 119():103-9. PubMed ID: 23769693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence for nicotinic and muscarinic receptors and their interaction in dog adrenal medulla.
    Tsujimoto A; Nishikawa T
    Eur J Pharmacol; 1975 Dec; 34(2):337-44. PubMed ID: 1234552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological evidence for nicotinic and muscarinic modulation of spinal cord reflexes.
    Ibrahim NA; Goldstein BD
    Neuropharmacology; 1989 Sep; 28(9):977-83. PubMed ID: 2812287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chemoreceptor stimulating agents on reflex bradycardia.
    Matsumoto S; Nagao T; Ibi A; Nakajima T
    Arch Int Pharmacodyn Ther; 1979 Jun; 239(2):296-307. PubMed ID: 39534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test.
    Addy NA; Nunes EJ; Wickham RJ
    Behav Brain Res; 2015 Jul; 288():54-62. PubMed ID: 25865152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phencyclidine: behavioral and biochemical evidence against the anticholinergic hypothesis.
    Johnson KM
    Pharmacol Biochem Behav; 1982 Jul; 17(1):53-7. PubMed ID: 7122667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.